Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Furling

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Nature Biomedical Engineering|February 13, 2021
Cas9 targeting of toxic foci of RNA repeatsDenis Furling
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[Misregulation of alternative splicing and microRNA processing in DM1 pathogenesis]Denis Furling
Trends in Cardiovascular Medicine|June 20, 2019
Cardiovascular manifestations of myotonic dystrophyKarim Wahbi, Denis Furling
Medecine Sciences : M/S|December 20, 2021
[How alternative splicing contributes to clathrin's structural plasticity]Gilles Moulay, Marc Bitoun, Denis Furling, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 6, 2019
FISH Protocol for Myotonic Dystrophy Type 1 CellsArnaud F Klein, Ludovic Arandel, Joelle Marie, et al.
Frontiers in Neurology|June 8, 2018
Cells of Matter-<i>In Vitro</i> Models for Myotonic DystrophyMagdalena Matloka, Arnaud F Klein, Frédérique Rau, et al.
Molecular Therapy. Nucleic Acids|December 20, 2019
miR-7 Restores Phenotypes in Myotonic Dystrophy Muscle Cells by Repressing Hyperactivated AutophagyMaria Sabater-Arcis, Ariadna Bargiela, Denis Furling, et al.
Journal of Cell Science|February 1, 2007
IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubesVirginie Jacquemin, Gillian Sandra Butler-Browne, Denis Furling, et al.
Frontiers in Genetics|December 28, 2020
A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1Nan Zhang, Brittani Bewick, Guangbin Xia, et al.
Nucleic Acids Research|September 22, 2010
Steroid receptor RNA activator protein binds to and counteracts SRA RNA-mediated activation of MyoD and muscle differentiationFlorent Hubé, Guillaume Velasco, Jérôme Rollin, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Nature Biomedical Engineering|February 13, 2021
Cas9 targeting of toxic foci of RNA repeatsDenis Furling
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[Misregulation of alternative splicing and microRNA processing in DM1 pathogenesis]Denis Furling
Trends in Cardiovascular Medicine|June 20, 2019
Cardiovascular manifestations of myotonic dystrophyKarim Wahbi, Denis Furling
Medecine Sciences : M/S|December 20, 2021
[How alternative splicing contributes to clathrin's structural plasticity]Gilles Moulay, Marc Bitoun, Denis Furling, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 6, 2019
FISH Protocol for Myotonic Dystrophy Type 1 CellsArnaud F Klein, Ludovic Arandel, Joelle Marie, et al.
Frontiers in Neurology|June 8, 2018
Cells of Matter-<i>In Vitro</i> Models for Myotonic DystrophyMagdalena Matloka, Arnaud F Klein, Frédérique Rau, et al.
Molecular Therapy. Nucleic Acids|December 20, 2019
miR-7 Restores Phenotypes in Myotonic Dystrophy Muscle Cells by Repressing Hyperactivated AutophagyMaria Sabater-Arcis, Ariadna Bargiela, Denis Furling, et al.
Journal of Cell Science|February 1, 2007
IL-13 mediates the recruitment of reserve cells for fusion during IGF-1-induced hypertrophy of human myotubesVirginie Jacquemin, Gillian Sandra Butler-Browne, Denis Furling, et al.
Frontiers in Genetics|December 28, 2020
A CRISPR-Cas13a Based Strategy That Tracks and Degrades Toxic RNA in Myotonic Dystrophy Type 1Nan Zhang, Brittani Bewick, Guangbin Xia, et al.
Nucleic Acids Research|September 22, 2010
Steroid receptor RNA activator protein binds to and counteracts SRA RNA-mediated activation of MyoD and muscle differentiationFlorent Hubé, Guillaume Velasco, Jérôme Rollin, et al.
Pageof 8